Use of Radioiodine after Thyroid Lobectomy in Patients with Differentiated Thyroid Cancer: Does It Change Outcomes?
AUTHORS
Kiernan
CM ,
Parikh
AA ,
Parks
LL ,
Solórzano
CC ,
. Journal of the American College of Surgeons. 2014 12 17; ().
- PMID: 25667136 [PubMed].
ABSTRACT
Radioiodine (RAI) lobe ablation in lieu of completion thyroidectomy is not recommended. This study describes RAI use patterns and outcomes in patients with well-differentiated thyroid cancer (DTC) after thyroid lobectomy (TL).
Radioiodine (RAI) lobe ablation in lieu of completion thyroidectomy is not recommended. This study describes RAI use patterns and outcomes in patients with well-differentiated thyroid cancer (DTC) after thyroid lobectomy (TL).
Tags: Alumni Publications 2014